Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127102481 | 12710248 | 1 | I | 20160801 | 20160801 | 20160902 | 20160902 | EXP | JP-AMGEN-JPNCT2016104435 | AMGEN | 65.00 | YR | E | F | Y | 54.50000 | KG | 20160901 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127102481 | 12710248 | 1 | PS | panitumumab | PANITUMUMAB | 1 | Intravenous drip | 320 MG, Q2WK | 320 | MG | Y | 125147 | 320 | MG | SOLUTION FOR INJECTION | QOW | |||
| 127102481 | 12710248 | 2 | SS | panitumumab | PANITUMUMAB | 1 | Intravenous drip | 320 MG, Q2WK | 320 | MG | Y | 125147 | 320 | MG | SOLUTION FOR INJECTION | QOW | |||
| 127102481 | 12710248 | 3 | SS | panitumumab | PANITUMUMAB | 1 | Intravenous drip | 320 MG, Q2WK | 320 | MG | Y | 125147 | 320 | MG | SOLUTION FOR INJECTION | QOW | |||
| 127102481 | 12710248 | 4 | SS | panitumumab | PANITUMUMAB | 1 | Intravenous drip | 320 MG, Q2WK | 320 | MG | Y | 125147 | 320 | MG | SOLUTION FOR INJECTION | QOW | |||
| 127102481 | 12710248 | 5 | C | OXALIPLATIN. | OXALIPLATIN | 1 | Intravenous drip | 120 MG, Q2WEEKS | U | 0 | 120 | MG | QOW | ||||||
| 127102481 | 12710248 | 6 | C | OXALIPLATIN. | OXALIPLATIN | 1 | Intravenous drip | 65 MG/M2, UNK | U | 0 | 65 | MG/M**2 | QOW | ||||||
| 127102481 | 12710248 | 7 | C | OXALIPLATIN. | OXALIPLATIN | 1 | Intravenous drip | 50 MG/M2, Q2WEEKS | U | 0 | 50 | MG/M**2 | QOW | ||||||
| 127102481 | 12710248 | 8 | C | OXALIPLATIN. | OXALIPLATIN | 1 | Intravenous drip | 50 MG/M2, Q2WEEKS | U | 0 | 50 | MG/M**2 | QOW | ||||||
| 127102481 | 12710248 | 9 | C | 5-FU /00098801/ | FLUOROURACIL | 1 | Intravenous bolus | 550 MG, Q2WK | 3550 | MG | U | 0 | 550 | MG | QOW | ||||
| 127102481 | 12710248 | 10 | C | 5-FU /00098801/ | FLUOROURACIL | 1 | Intravenous drip | 3550 MG, Q2WEEKS | 3550 | MG | U | 0 | 3550 | MG | QOW | ||||
| 127102481 | 12710248 | 11 | C | 5-FU /00098801/ | FLUOROURACIL | 1 | Intravenous bolus | 168 MG/M2, Q2WK | 3550 | MG | U | 0 | 168 | MG/M**2 | QOW | ||||
| 127102481 | 12710248 | 12 | C | 5-FU /00098801/ | FLUOROURACIL | 1 | Intravenous drip | 2000 MG/M2, Q2WEEKS | 3550 | MG | U | 0 | 2000 | MG/M**2 | QOW | ||||
| 127102481 | 12710248 | 13 | C | 5-FU /00098801/ | FLUOROURACIL | 1 | Intravenous drip | 1600 MG/M2, Q2WEEKS | 3550 | MG | U | 0 | 1600 | MG/M**2 | QOW | ||||
| 127102481 | 12710248 | 14 | C | 5-FU /00098801/ | FLUOROURACIL | 1 | Intravenous drip | 1600 MG/M2, Q2WEEKS | 3550 | MG | U | 0 | 1600 | MG/M**2 | QOW | ||||
| 127102481 | 12710248 | 15 | C | CALCIUM LEVOFOLINATE | LEVOLEUCOVORIN CALCIUM | 1 | Intravenous drip | 275 MG, Q2WEEKS | 275 | MG | U | 0 | 275 | MG | QOW | ||||
| 127102481 | 12710248 | 16 | C | CALCIUM LEVOFOLINATE | LEVOLEUCOVORIN CALCIUM | 1 | Intravenous drip | UNK UNK, Q2WEEKS | 275 | MG | U | 0 | QOW |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127102481 | 12710248 | 1 | Colon cancer |
| 127102481 | 12710248 | 5 | Colon cancer |
| 127102481 | 12710248 | 9 | Colon cancer |
| 127102481 | 12710248 | 15 | Colon cancer |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127102481 | 12710248 | OT |
| 127102481 | 12710248 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127102481 | 12710248 | Decreased appetite | |
| 127102481 | 12710248 | Fatigue | |
| 127102481 | 12710248 | Febrile neutropenia | |
| 127102481 | 12710248 | Fracture | |
| 127102481 | 12710248 | Neutrophil count decreased | |
| 127102481 | 12710248 | Platelet count decreased | |
| 127102481 | 12710248 | White blood cell count decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127102481 | 12710248 | 1 | 20160419 | 20160419 | 0 | |
| 127102481 | 12710248 | 2 | 20160520 | 20160520 | 0 | |
| 127102481 | 12710248 | 3 | 20160617 | 20160617 | 0 | |
| 127102481 | 12710248 | 4 | 20160712 | 20160712 | 0 | |
| 127102481 | 12710248 | 5 | 20160419 | 20160419 | 0 | |
| 127102481 | 12710248 | 6 | 20160520 | 20160520 | 0 | |
| 127102481 | 12710248 | 7 | 20160617 | 20160617 | 0 | |
| 127102481 | 12710248 | 8 | 20160712 | 20160712 | 0 | |
| 127102481 | 12710248 | 9 | 20160419 | 20160419 | 0 | |
| 127102481 | 12710248 | 10 | 20160419 | 20160419 | 0 | |
| 127102481 | 12710248 | 11 | 20160520 | 20160520 | 0 | |
| 127102481 | 12710248 | 12 | 20160520 | 20160520 | 0 | |
| 127102481 | 12710248 | 13 | 20160617 | 20160617 | 0 | |
| 127102481 | 12710248 | 14 | 20160712 | 20160712 | 0 | |
| 127102481 | 12710248 | 15 | 20160419 | 20160419 | 0 | |
| 127102481 | 12710248 | 16 | 20160520 | 0 |